{"hands_on_practices": [{"introduction": "Immunologic self-tolerance begins in the thymus, where developing T cells are screened for self-reactivity. This practice ([@problem_id:4853839]) challenges you to build a probabilistic model of this crucial process, known as negative selection. By combining a biophysical score for self-reactivity with a probabilistic deletion rule, you will quantify how the immune system purges potentially autoreactive T cells to establish central tolerance.", "problem": "A central challenge in internal medicine is to understand how central tolerance prevents autoimmunity while allowing a diverse T cell repertoire. Consider a simplified immunobiological model of thymic negative selection in which each newly generated T cell clone is assigned a nonnegative T cell receptor (TCR) self-reactivity score $s$, which aggregates the strength and breadth of self-peptide recognition in the thymus. Negative selection deletes a clone with a probability that increases with $s$ and saturates near certainty for sufficiently high $s$. Assume the following:\n\n1. The probability that a clone with score $s$ is deleted in negative selection is given by $p_{\\mathrm{del}}(s) = 1 - \\exp(-\\alpha s)$, where $\\alpha > 0$ is a constant capturing the effective intensity of self-antigen display and co-stimulatory context in the thymus.\n\n2. The distribution of $s$ across new clones is modeled as a Gamma distribution with shape parameter $k > 0$ and scale parameter $\\theta > 0$. That is, $s \\sim \\mathrm{Gamma}(k, \\theta)$. Biologically, $k$ reflects the effective number of independent self-peptide interaction contributions and $\\theta$ reflects their scale.\n\nUsing only core probability definitions and well-tested facts about expectation and the Gamma family, derive from first principles an expression for the expected fraction of clones that escape deletion (that is, survive negative selection) across the entire cohort, as a function of $\\alpha$, $k$, and $\\theta$. Then evaluate this expected fraction for the parameter values $k=3$, $\\theta=0.5$, and $\\alpha=1.2$. Express your final numerical answer as a unitless decimal fraction rounded to four significant figures.", "solution": "The objective is to find the expected fraction of T cell clones that survive negative selection. Let $S$ be the random variable representing the TCR self-reactivity score. According to the problem statement, $S$ follows a Gamma distribution with shape parameter $k > 0$ and scale parameter $\\theta > 0$. We write this as $S \\sim \\mathrm{Gamma}(k, \\theta)$. The probability density function (PDF) of $S$ is given by:\n$$ f_S(s; k, \\theta) = \\frac{s^{k-1} \\exp(-s/\\theta)}{\\theta^k \\Gamma(k)} \\quad \\text{for } s \\ge 0 $$\nwhere $\\Gamma(k)$ is the Gamma function.\n\nThe probability that a clone with a specific score $s$ is deleted is given as $p_{\\mathrm{del}}(s) = 1 - \\exp(-\\alpha s)$, where $\\alpha > 0$. The probability that a clone with score $s$ is *not* deleted, i.e., it survives, is the complement:\n$$ p_{\\mathrm{surv}}(s) = 1 - p_{\\mathrm{del}}(s) = 1 - (1 - \\exp(-\\alpha s)) = \\exp(-\\alpha s) $$\n\nThe expected fraction of clones that escape deletion is the expected value of this survival probability, averaged over the distribution of all possible scores $s$. This is the expectation of the function $p_{\\mathrm{surv}}(S)$ where $S$ is the random variable. Let this expected fraction be denoted by $F_{\\mathrm{surv}}$.\n$$ F_{\\mathrm{surv}} = E[p_{\\mathrm{surv}}(S)] = E[\\exp(-\\alpha S)] $$\n\nAccording to the definition of expectation for a continuous random variable, this is calculated by the integral:\n$$ F_{\\mathrm{surv}} = \\int_{0}^{\\infty} p_{\\mathrm{surv}}(s) f_S(s) ds = \\int_{0}^{\\infty} \\exp(-\\alpha s) \\frac{s^{k-1} \\exp(-s/\\theta)}{\\theta^k \\Gamma(k)} ds $$\n\nThis expression $E[\\exp(-\\alpha S)]$ is precisely the definition of the moment-generating function (MGF) of the random variable $S$, denoted $M_S(t)$, evaluated at $t = -\\alpha$. The MGF of a random variable $X$ is defined as $M_X(t) = E[\\exp(tX)]$.\n\nA well-established property of the Gamma distribution $S \\sim \\mathrm{Gamma}(k, \\theta)$ is that its moment-generating function is given by:\n$$ M_S(t) = (1 - \\theta t)^{-k} $$\nThis MGF is defined for $t  1/\\theta$.\n\nTo find the expected fraction of survivors, we evaluate the MGF at $t = -\\alpha$:\n$$ F_{\\mathrm{surv}} = M_S(-\\alpha) = (1 - \\theta(-\\alpha))^{-k} $$\nThe condition for the MGF to be defined is $-\\alpha  1/\\theta$. Since the problem specifies $\\alpha > 0$ and $\\theta > 0$, this condition is always satisfied.\n\nSimplifying the expression, we obtain the general formula for the expected fraction of surviving clones:\n$$ F_{\\mathrm{surv}}(\\alpha, k, \\theta) = (1 + \\alpha\\theta)^{-k} $$\nThis is the desired expression derived from first principles, using the definition of expectation and a standard property of the Gamma distribution.\n\nNext, we are asked to evaluate this expression for the specific parameter values $k=3$, $\\theta=0.5$, and $\\alpha=1.2$.\nSubstituting these values into the derived formula:\n$$ F_{\\mathrm{surv}} = (1 + (1.2)(0.5))^{-3} $$\nFirst, calculate the product $\\alpha\\theta$:\n$$ \\alpha\\theta = 1.2 \\times 0.5 = 0.6 $$\nNow substitute this back into the expression:\n$$ F_{\\mathrm{surv}} = (1 + 0.6)^{-3} = (1.6)^{-3} $$\nThis can be written as:\n$$ F_{\\mathrm{surv}} = \\frac{1}{1.6^3} $$\nWe calculate $1.6^3$:\n$$ 1.6^3 = 1.6 \\times 1.6 \\times 1.6 = 2.56 \\times 1.6 = 4.096 $$\nTherefore, the expected fraction is:\n$$ F_{\\mathrm{surv}} = \\frac{1}{4.096} $$\nPerforming the division gives:\n$$ F_{\\mathrm{surv}} = 0.244140625 $$\n\nThe problem requires the final numerical answer to be rounded to four significant figures. The first four significant figures are $2$, $4$, $4$, and $1$. The fifth significant figure is $4$. Since $4  5$, we round down.\n$$ F_{\\mathrm{surv}} \\approx 0.2441 $$\nThis is the final numerical value for the expected fraction of clones that escape deletion under the given parameters.", "answer": "$$\\boxed{0.2441}$$", "id": "4853839"}, {"introduction": "T cells that survive thymic selection must still be carefully regulated in the periphery to prevent autoimmunity. This exercise ([@problem_id:4853872]) delves into the \"two-signal\" model of T cell activation by focusing on the competition between the costimulatory receptor CD28 and the inhibitory receptor CTLA-4. You will develop a quantitative model to determine the precise ligand concentration at which the balance of these opposing signals tips, providing insight into how T cell responses are fine-tuned.", "problem": "A naïve human T cell encounters an antigen-presenting cell (APC) displaying the B7 family ligands (CD80/CD86). Two T cell surface receptors bind these ligands: Cluster of Differentiation 28 (CD28), which delivers a costimulatory signal, and Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4), which delivers an inhibitory signal. Assume monovalent binding for each receptor–ligand pair, rapid equilibrium, and that the free ligand concentration is spatially uniform and not substantially depleted by binding, so the Law of Mass Action applies independently to each receptor type. The dissociation constant is defined by $K_d = \\frac{[R][L]}{[RL]}$, where $[R]$ is the free receptor concentration, $[L]$ is the free ligand concentration, and $[RL]$ is the concentration of receptor–ligand complex. Let the total receptor number per cell be $N_{28}$ for CD28 and $N_{\\mathrm{CTLA4}}$ for CTLA-4.\n\nDefine the fraction of each receptor occupied by ligand as $f_{i}([L])$ for $i \\in \\{28, \\mathrm{CTLA4}\\}$, and assume that each occupied CD28 receptor contributes a costimulatory signal of magnitude $k_{\\mathrm{costim}}$ (arbitrary units) and each occupied CTLA-4 receptor contributes an inhibitory signal of magnitude $k_{\\mathrm{inhib}}$ (arbitrary units). The net tone of T cell signaling is modeled as\n$$\nS([L]) = k_{\\mathrm{costim}}\\,N_{28}\\,f_{28}([L]) - k_{\\mathrm{inhib}}\\,N_{\\mathrm{CTLA4}}\\,f_{\\mathrm{CTLA4}}([L]).\n$$\nA positive $S([L])$ indicates net costimulation, while a negative $S([L])$ indicates net inhibition.\n\nUsing the Law of Mass Action to derive $f_{i}([L])$ from $K_{d,i}$ and the definitions above, determine the free ligand concentration $[L]^{*}$ (in molar units) at which the net tone switches sign, that is, $S([L]^{*}) = 0$, given the following biologically plausible parameters:\n- $N_{28} = 8.0 \\times 10^{4}$ receptors per cell,\n- $N_{\\mathrm{CTLA4}} = 1.0 \\times 10^{4}$ receptors per cell,\n- $K_{d,28} = 1.0 \\times 10^{-6}\\ \\mathrm{M}$,\n- $K_{d,\\mathrm{CTLA4}} = 2.0 \\times 10^{-8}\\ \\mathrm{M}$,\n- $k_{\\mathrm{costim}} = 1.0$ (arbitrary units per occupied CD28),\n- $k_{\\mathrm{inhib}} = 3.0$ (arbitrary units per occupied CTLA-4).\n\nExpress your final answer for $[L]^{*}$ in $\\mathrm{M}$ and round to three significant figures. Based on this threshold, the APC microenvironment spans $[L]$ values from $10^{-9}$ to $10^{-6}\\ \\mathrm{M}$; the sign of $S([L])$ across this span can then be inferred from the value of $[L]^{*}$, but your final answer must be only the numerical value of $[L]^{*}$.", "solution": "The primary objective is to determine the free ligand concentration, denoted as $[L]^{*}$, at which the net signaling tone $S([L]^{*})$ is equal to zero. The net tone is given by the difference between the total costimulatory signal and the total inhibitory signal:\n$$\nS([L]) = k_{\\mathrm{costim}}\\,N_{28}\\,f_{28}([L]) - k_{\\mathrm{inhib}}\\,N_{\\mathrm{CTLA4}}\\,f_{\\mathrm{CTLA4}}([L])\n$$\nHere, $N_i$ is the total number of receptors of type $i$, $k_i$ is the signal strength per occupied receptor of type $i$, and $f_i([L])$ is the fraction of receptors of type $i$ that are occupied by the ligand at a free ligand concentration of $[L]$.\n\nFirst, we must derive an expression for the fractional occupancy, $f_i([L])$. The problem states that the system is at rapid equilibrium and follows the Law of Mass Action. For a generic receptor $R$ and ligand $L$, the binding reaction is $R + L \\rightleftharpoons RL$. The dissociation constant, $K_{d,i}$, is defined as:\n$$\nK_{d,i} = \\frac{[R_i][L]}{[R_iL]}\n$$\nwhere $[R_i]$ is the concentration of free receptors of type $i$, $[L]$ is the concentration of free ligand, and $[R_iL]$ is the concentration of the receptor-ligand complex.\n\nThe fractional occupancy, $f_i$, is the ratio of the number of occupied receptors to the total number of receptors. Since concentrations are proportional to numbers in a given volume, we can write:\n$$\nf_i([L]) = \\frac{[R_iL]}{[R_{i, \\text{total}}]}\n$$\nThe total concentration of receptors, $[R_{i, \\text{total}}]$, is the sum of the free and bound receptor concentrations:\n$$\n[R_{i, \\text{total}}] = [R_i] + [R_iL]\n$$\nFrom the definition of $K_{d,i}$, we can express the free receptor concentration as $[R_i] = \\frac{K_{d,i}[R_iL]}{[L]}$. Substituting this into the equation for the total receptor concentration gives:\n$$\n[R_{i, \\text{total}}] = \\frac{K_{d,i}[R_iL]}{[L]} + [R_iL] = [R_iL] \\left( \\frac{K_{d,i}}{[L]} + 1 \\right) = [R_iL] \\frac{K_{d,i} + [L]}{[L]}\n$$\nRearranging this equation to solve for the fractional occupancy $f_i([L]) = \\frac{[R_iL]}{[R_{i, \\text{total}}]}$ yields the standard single-site binding isotherm:\n$$\nf_i([L]) = \\frac{[L]}{K_{d,i} + [L]}\n$$\nNow, we can substitute this expression for $f_{28}([L])$ and $f_{\\mathrm{CTLA4}}([L])$ into the equation for the net signaling tone, $S([L])$. We seek the concentration $[L]^{*}$ where $S([L]^{*}) = 0$:\n$$\nk_{\\mathrm{costim}}\\,N_{28}\\,\\frac{[L]^{*}}{K_{d,28} + [L]^{*}} - k_{\\mathrm{inhib}}\\,N_{\\mathrm{CTLA4}}\\,\\frac{[L]^{*}}{K_{d,\\mathrm{CTLA4}} + [L]^{*}} = 0\n$$\nOne trivial solution is $[L]^{*} = 0$. However, the problem asks for the concentration at which the tone *switches* sign, which implies a non-zero threshold. For $[L]^{*} \\neq 0$, we can divide the entire equation by $[L]^{*}$:\n$$\n\\frac{k_{\\mathrm{costim}}\\,N_{28}}{K_{d,28} + [L]^{*}} = \\frac{k_{\\mathrm{inhib}}\\,N_{\\mathrm{CTLA4}}}{K_{d,\\mathrm{CTLA4}} + [L]^{*}}\n$$\nWe now solve this equation for $[L]^{*}$. Cross-multiplication gives:\n$$\nk_{\\mathrm{costim}}\\,N_{28}(K_{d,\\mathrm{CTLA4}} + [L]^{*}) = k_{\\mathrm{inhib}}\\,N_{\\mathrm{CTLA4}}(K_{d,28} + [L]^{*})\n$$\nExpanding both sides:\n$$\nk_{\\mathrm{costim}}\\,N_{28}\\,K_{d,\\mathrm{CTLA4}} + k_{\\mathrm{costim}}\\,N_{28}\\,[L]^{*} = k_{\\mathrm{inhib}}\\,N_{\\mathrm{CTLA4}}\\,K_{d,28} + k_{\\mathrm{inhib}}\\,N_{\\mathrm{CTLA4}}\\,[L]^{*}\n$$\nGroup the terms containing $[L]^{*}$ on one side and the constant terms on the other:\n$$\n[L]^{*} (k_{\\mathrm{costim}}\\,N_{28} - k_{\\mathrm{inhib}}\\,N_{\\mathrm{CTLA4}}) = k_{\\mathrm{inhib}}\\,N_{\\mathrm{CTLA4}}\\,K_{d,28} - k_{\\mathrm{costim}}\\,N_{28}\\,K_{d,\\mathrm{CTLA4}}\n$$\nIsolating $[L]^{*}$ yields the analytical solution:\n$$\n[L]^{*} = \\frac{k_{\\mathrm{inhib}}\\,N_{\\mathrm{CTLA4}}\\,K_{d,28} - k_{\\mathrm{costim}}\\,N_{28}\\,K_{d,\\mathrm{CTLA4}}}{k_{\\mathrm{costim}}\\,N_{28} - k_{\\mathrm{inhib}}\\,N_{\\mathrm{CTLA4}}}\n$$\nWe now substitute the provided parameter values:\n- $N_{28} = 8.0 \\times 10^{4}$\n- $N_{\\mathrm{CTLA4}} = 1.0 \\times 10^{4}$\n- $K_{d,28} = 1.0 \\times 10^{-6}\\ \\mathrm{M}$\n- $K_{d,\\mathrm{CTLA4}} = 2.0 \\times 10^{-8}\\ \\mathrm{M}$\n- $k_{\\mathrm{costim}} = 1.0$\n- $k_{\\mathrm{inhib}} = 3.0$\n\nLet's calculate the numerator and the denominator separately.\nThe numerator is:\n$$\n(3.0)(1.0 \\times 10^{4})(1.0 \\times 10^{-6}) - (1.0)(8.0 \\times 10^{4})(2.0 \\times 10^{-8})\n$$\n$$\n= (3.0 \\times 10^{-2}) - (16.0 \\times 10^{-4})\n$$\n$$\n= (3.0 \\times 10^{-2}) - (0.16 \\times 10^{-2}) = 2.84 \\times 10^{-2}\n$$\nThe denominator is:\n$$\n(1.0)(8.0 \\times 10^{4}) - (3.0)(1.0 \\times 10^{4})\n$$\n$$\n= 8.0 \\times 10^{4} - 3.0 \\times 10^{4} = 5.0 \\times 10^{4}\n$$\nNow, we compute the final value for $[L]^{*}$:\n$$\n[L]^{*} = \\frac{2.84 \\times 10^{-2}}{5.0 \\times 10^{4}} = \\frac{2.84}{5.0} \\times 10^{-2-4} = 0.568 \\times 10^{-6}\\ \\mathrm{M}\n$$\nExpressed in standard scientific notation and rounded to three significant figures as required, the result is:\n$$\n[L]^{*} = 5.68 \\times 10^{-7}\\ \\mathrm{M}\n$$\nThis value represents the ligand concentration at which the inhibitory signal from CTLA-4 exactly balances the costimulatory signal from CD28.", "answer": "$$\\boxed{5.68 \\times 10^{-7}}$$", "id": "4853872"}, {"introduction": "The clinical manifestation of autoimmunity is the tragic outcome of failed tolerance mechanisms. This problem ([@problem_id:4853828]) applies the principles of immune-mediated damage to a real-world disease, Type 1 Diabetes, by modeling the progressive destruction of pancreatic beta cells. By constructing and solving a differential equation that accounts for both direct CD8$^+$ T cell cytotoxicity and bystander damage, you will predict the decline in a key clinical biomarker, C-peptide.", "problem": "A newly diagnosed adult with Type 1 Diabetes Mellitus (T1D) exhibits a break in immunologic tolerance characterized by sustained infiltration of cluster of differentiation 8 positive (CD8$^+$) cytotoxic T lymphocytes in pancreatic islets and elevated local proinflammatory cytokines, including interferon gamma (IFN-$\\gamma$) and tumor necrosis factor alpha (TNF-$\\alpha$). To mechanistically predict the decline of C-peptide, you will construct a minimal, biologically grounded model for beta-cell loss that incorporates both CD8$^+$ T cell cytotoxicity and cytokine-mediated bystander damage, and then link viable beta-cell mass to plasma C-peptide.\n\nUse the following foundational facts:\n- Beta-cell death due to CD8$^+$ T cells arises from effector-target encounters; under well-mixed conditions this is approximated by mass-action kinetics, making the instantaneous cytotoxic hazard proportional to the product of effector cell density and beta-cell mass.\n- Proinflammatory cytokines produced by activated CD8$^+$ T cells impose additive bystander death on beta cells; the instantaneous hazard is proportional to the local cytokine concentration.\n- Plasma C-peptide concentration is proportional to the functional beta-cell mass.\n\nLet $B(t)$ be the normalized functional beta-cell mass (unitless), $T(t)$ be the normalized effector CD8$^+$ T cell density (unitless), and $Y(t)$ be the normalized local cytokine concentration (unitless). Suppose that after an early transient, the effector population has reached a quasi-steady level $T(t) = T_{s}$, and the cytokine pool obeys production-clearance dynamics $dY/dt = pT_{s} - \\delta Y$, reaching a steady state $Y_{s} = pT_{s}/\\delta$. Assume that beta-cell loss is governed by\n$$\n\\frac{dB}{dt} = -\\left(k_{1}T_{s} + k_{2}Y_{s}\\right)B,\n$$\nand that plasma C-peptide $P(t)$ satisfies $P(t) = sB(t)$, where $s$ is a constant scaling the normalized mass to concentration.\n\nParameter values:\n- Initial normalized mass $B(0) = 1$.\n- Effector quasi-steady level $T_{s} = 1$.\n- Cytokine production rate $p = 0.235$ day$^{-1}$.\n- Cytokine clearance rate $\\delta = 0.1$ day$^{-1}$.\n- Direct cytotoxicity coefficient $k_{1} = 0.0015$ day$^{-1}$.\n- Cytokine-mediated bystander damage coefficient $k_{2} = 0.001$ day$^{-1}$.\n- C-peptide scaling $s = 0.90$ nmol/L per unit of normalized beta-cell mass.\n\nStarting only from the foundational facts and the model structure above, derive the expression for $P(t)$ and compute the predicted plasma C-peptide $P(t)$ at $t = 365$ days. Round your final answer to three significant figures. Express the final C-peptide concentration in nmol/L.", "solution": "The dynamics of the normalized functional beta-cell mass, $B(t)$, are described by the first-order linear homogeneous ordinary differential equation:\n$$\n\\frac{dB}{dt} = -\\left(k_{1}T_{s} + k_{2}Y_{s}\\right)B\n$$\nThe problem states that the effector T cell population is at a quasi-steady level $T_{s}$, and the local cytokine concentration has also reached a steady state, $Y_{s}$, determined by the balance of production and clearance. The expression for $Y_{s}$ is given as:\n$$\nY_{s} = \\frac{pT_{s}}{\\delta}\n$$\nSubstituting the given parameter values for $p$, $T_{s}$, and $\\delta$:\n$$\nY_{s} = \\frac{(0.235\\,\\text{day}^{-1})(1)}{0.1\\,\\text{day}^{-1}} = 2.35\n$$\nThis value is unitless, consistent with the definition of $Y(t)$ as a normalized concentration.\n\nThe term in the parenthesis in the differential equation for $B(t)$ is an effective rate constant for beta-cell loss, which we will denote as $k_{\\text{eff}}$. This constant combines the effects of direct cytotoxicity and cytokine-mediated bystander damage.\n$$\nk_{\\text{eff}} = k_{1}T_{s} + k_{2}Y_{s}\n$$\nSubstituting the numerical values for $k_{1}$, $T_{s}$, $k_{2}$, and the calculated value for $Y_{s}$:\n$$\nk_{\\text{eff}} = (0.0015\\,\\text{day}^{-1})(1) + (0.001\\,\\text{day}^{-1})(2.35)\n$$\n$$\nk_{\\text{eff}} = 0.0015\\,\\text{day}^{-1} + 0.00235\\,\\text{day}^{-1} = 0.00385\\,\\text{day}^{-1}\n$$\nThe differential equation for $B(t)$ simplifies to:\n$$\n\\frac{dB}{dt} = -k_{\\text{eff}}B\n$$\nThis is a standard exponential decay model. The general solution is found by separation of variables:\n$$\n\\int \\frac{dB}{B} = \\int -k_{\\text{eff}}\\,dt\n$$\n$$\n\\ln(B) = -k_{\\text{eff}}t + C\n$$\nwhere $C$ is the constant of integration. Exponentiating both sides gives:\n$$\nB(t) = \\exp(-k_{\\text{eff}}t + C) = A\\exp(-k_{\\text{eff}}t)\n$$\nwhere $A = \\exp(C)$. We use the initial condition $B(0) = 1$ to determine $A$:\n$$\nB(0) = 1 = A\\exp(-k_{\\text{eff}} \\cdot 0) = A \\cdot 1\n$$\nThus, $A = 1$. The specific solution for the normalized beta-cell mass is:\n$$\nB(t) = \\exp(-k_{\\text{eff}}t)\n$$\nThe plasma C-peptide concentration, $P(t)$, is proportional to the functional beta-cell mass, $B(t)$, via the scaling constant $s$:\n$$\nP(t) = sB(t)\n$$\nSubstituting the derived expression for $B(t)$, we obtain the explicit expression for $P(t)$:\n$$\nP(t) = s\\exp(-k_{\\text{eff}}t)\n$$\nIn terms of the fundamental parameters, the derived expression is:\n$$\nP(t) = s\\exp\\left(-\\left(k_{1}T_{s} + k_{2}\\frac{pT_{s}}{\\delta}\\right)t\\right)\n$$\nNow, we compute the value of $P(t)$ at $t = 365$ days.\n$$\nP(365) = s\\exp(-k_{\\text{eff}} \\cdot 365)\n$$\nSubstituting the values $s = 0.90$ nmol/L and $k_{\\text{eff}} = 0.00385$ day$^{-1}$:\n$$\nP(365) = 0.90 \\cdot \\exp(-0.00385 \\cdot 365)\n$$\nFirst, calculate the exponent:\n$$\n-0.00385 \\times 365 = -1.40525\n$$\nNow, calculate $P(365)$:\n$$\nP(365) = 0.90 \\cdot \\exp(-1.40525) \\approx 0.90 \\cdot 0.245298 = 0.2207682\\,\\text{nmol/L}\n$$\nThe problem requires the answer to be rounded to three significant figures. The fourth significant figure is $7$, so we round up the third significant figure.\n$$\nP(365) \\approx 0.221\\,\\text{nmol/L}\n$$", "answer": "$$\n\\boxed{0.221}\n$$", "id": "4853828"}]}